Evinacumab, Novel Lipid-Lowerer, Extends Promise in Phase 2 Results ...Middle East

Medscape - News
Treatment with evinacumab safely reduced LDL cholesterol levels in patients with treatment-refractory hypercholesterolemia in a multicenter, phase 2 study of 272 patients treated for 16 weeks. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Evinacumab, Novel Lipid-Lowerer, Extends Promise in Phase 2 Results )

Apple Storegoogle play

Also on site :